Primary prevention of heart failure: An update

Current Opinion in Cardiology

Volumn 25, Issue 5, 2010, Pages 478-483

  Dupree, Carla S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

diet; heart failure; hypertension; lifestyle; prevention

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; INDAPAMIDE PLUS PERINDOPRIL; ISRADIPINE; LACIDIPINE; NICARDIPINE; NIFEDIPINE; NISOLDIPINE; NITRENDIPINE; OXPRENOLOL; PINDOLOL; PROPRANOLOL; SOTALOL; THIAZIDE DIURETIC AGENT; VERAPAMIL; ANTIHYPERTENSIVE AGENT;

CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DIABETIC HYPERTENSION; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; HEART FAILURE; HEART PACING; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; AGED;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; HEART FAILURE; HUMANS; RECEPTORS, ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONISTS;

EID: 77955433269     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32833cd550     Document Type: Review

References (20)

1. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 2005; 26:1115-1140.
2. American Heart Association. Heart disease and stroke statistics: 2010 update. Dallas, Texas: American Heart Association; 2010.
3. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Hyattsville, Maryland, National Center for Health Statistics. Natl Health Stat Report (in press).
4. Arnold JM, Howlett JG, Dorian P, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol 2007; 23:21-45.
5. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the Adult: Summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 2005; 46:e1-e82.
6. Heart Failure Society of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006; 12:10-38.
7. Schocken DD, Benjamin EJ, Fonarow GC, et al. Prevention of heart failure: A scientific statement from the American Heart Association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation 2008; 117:2544-2565.
8. Dupree CS. Primary prevention of heart failure: What is the evidence? Curr Opin Cardiol 2009; 24:142-147. Reviews the risk factors and clinical trials that report the efficacy of treating hypertensive, diabetic, and high-risk patients in the prevention of heart failure.
9. Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, et al. Epidemiology of incident heart failure in a contemporary elderly cohort. The Health, Aging, and Body Composition Study. Arch Intern Med 2009; 169:708-715.
10. Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young Adults. N Engl J Med 2009; 360:1179-1190.
11. Djousse L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 2009; 302:394-400. In a cohort of healthy male physicians, adherence to none of healthy lifestyle factors was associated with a 21.2% lifetime risk of heart failure compared with a 10.1% incidence in participants who adhered to at least four factors.
12. Levitan EB, Wolk A, Mittleman MA. Consistency with the DASH diet and incidence of heart failure. Arch Intern Med 2009; 169:851-857. Healthy women in the Swedish Mammography cohort in the top quartile of adherence to the DASH diet had a 37% lower rate of heart failure after adjustment for multiple factors.
13. Law MR, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomized trials in the context of expectations fromprospective epidemiological studies.BMJ2009; 338:b1665. This meta-analysis demonstrated that drugs other than calcium channel blockers (with the exception of noncardioselective β blockers) reduced the incidence of heart failure by 24% (19-28%).
14. Costanzo P, Perrone-Filardi P, PetrettaM, et al. Calcium channel blockers and cardiovascular outcomes: A meta-analysis of 175 634 patients. J Hypertens 2009; 27:1136-1151.
15. Vedecchia P, Angeli F, Cavallini C, et al. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: A meta-analysis. Eur Heart J 2009; 30:679-688. This meta-analysis found that the risk of heart failure decreased by 24% (P<0.001) for each 5mmHg reduction in systolic BP. Over and beyond BP reduction, the protective effect of ACE-inhibitors and angiotensin-receptor blockers is greater than that of calcium channel blockers, which were associated with an 18% higher risk of heart failure.
16. Arima H, Anderson C, Omae T, et al. Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: The PROGRESS trial. J Hypertens 2010; 28:395-400.
17. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289:2560-2572.
18. The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1578-1585.
19. Perreault S, Dragomir A, White M, et al. Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Intern Med 2009; 266:207-218.
20. Cheuk-Man Y, Chan JY, Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009; 361:2123-2134.